# Bartonella-associated glomerulonephritis without endocarditis in a renal transplant recipient

**Authors:** Grace A. Schaack, Rene Bulnes, Deborah Jebakumar, Allen R. Hendricks, Andrew E. Clark

PMC · DOI: 10.1128/asmcr.00092-25 · ASM Case Reports · 2025-10-07

## TL;DR

A renal transplant recipient developed kidney disease caused by Bartonella bacteria without heart infection, highlighting the need for careful diagnosis in immunocompromised patients.

## Contribution

This case expands understanding of Bartonella-associated glomerulonephritis occurring without endocarditis in transplant recipients.

## Key findings

- Bartonella henselae can cause glomerulonephritis in renal transplant recipients without endocarditis.
- Diagnosis relies on serology and molecular testing due to poor culture sensitivity.
- Immunocompromised patients with cat or flea exposure should be evaluated for Bartonella.

## Abstract

Bartonella henselae is a fastidious gram-negative rod that can cause systemic disease in immunocompromised patients. Infection may be complicated by glomerulonephritis, often in the setting of culture-negative infective endocarditis. The histologic pattern of Bartonella-associated glomerulonephritis is variable and often difficult to distinguish from non-infectious causes of glomerulonephritis by histopathology. Prompt, accurate diagnosis is further complicated by the poor sensitivity of routine culture methods for the detection of B. henselae, and serology or adjunctive molecular testing is typically required for microbiologic diagnosis.

A middle-aged male renal transplant recipient was admitted to our hospital with fever, nausea, vomiting, diarrhea, and laboratory evidence of acute kidney injury. A thorough infectious disease work-up revealed markedly elevated B. henselae immunoglobulin G and immunoglobulin M titers and significant exposures to cats and fleas. A biopsy of the renal allograft revealed crescentic glomerulonephritis with immune complex deposition. No definitive evidence of infective endocarditis was found. The patient was started on renal replacement therapy and treated for disseminated bartonellosis with doxycycline and rifabutin.

The diagnosis of Bartonella-associated glomerulonephritis in immunocompromised patients can be challenging from both the clinical and histopathologic perspectives. A high degree of clinical suspicion in patients with relevant risk factors is important for prompt diagnosis and treatment. Regardless of the presence or absence of typical signs and symptoms of cat scratch disease and/or infective endocarditis, Bartonella spp. should be included in the differential diagnosis of glomerulonephritis in solid-organ transplant recipients and other immunocompromised patients with cats or other relevant exposures.

## Linked entities

- **Chemicals:** doxycycline (PubChem CID 54671203)
- **Diseases:** glomerulonephritis (MONDO:0002462), cat scratch disease (MONDO:0005692), infective endocarditis (MONDO:0000565), acute kidney injury (MONDO:0002492)
- **Species:** Bartonella henselae (taxon 38323)

## Full-text entities

- **Diseases:** fever (MESH:D005334), endocarditis (MESH:D004696), infectious disease (MESH:D003141), cat scratch disease (MESH:D002372), bartonellosis (MESH:D001474), diarrhea (MESH:D003967), nausea (MESH:D009325), Infection (MESH:D007239), acute kidney injury (MESH:D058186), vomiting (MESH:D014839), systemic disease (MESH:D034721), glomerulonephritis (MESH:D005921)
- **Chemicals:** rifabutin (MESH:D017828), doxycycline (MESH:D004318)
- **Species:** Homo sapiens (human, species) [taxon 9606], Felis catus (cat, species) [taxon 9685], Bartonella henselae (species) [taxon 38323]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12584172/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12584172/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12584172/full.md

---
Source: https://tomesphere.com/paper/PMC12584172